Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...

Neurology residents explore Parkinson's care, research advances and career opportunities at the 2026 MDS-PAS Movement Disorders School.

The U.S. Food and Drug Administration (FDA) has approved tavapadon, a once-daily oral medication for the treatment of motor symptoms of Parkinson’s disease. Tavapadon, which will be sold under the ...

On September 9, 2026, Michael J. Fox received the 2026 Lasker~Bloomberg Public Service Award, one of the nation’s highest honors in biomedical science, recognizing his work to empower the voices of ...

NEW YORK (September 9, 2026) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today celebrates founder Michael J. Fox as the recipient of the 2026 Lasker~Bloomberg Public Service Award, ...

Editor’s note: On Tuesday, May 26, 2026, Vermont Governor Phil Scott signed H. 739 into law, making Vermont first in the United States to ban paraquat, a pesticide linked to increased Parkinson’s ...

Art could play a meaningful role in supporting brain health and daily life with Parkinson’s. Whether you’re exploring your own creative outlet or enjoying the work of others, engaging with art could ...

NEW YORK, May 5, 2026 /PRNewswire/ — The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which sponsors the landmark Parkinson’s Progression Markers Initiative (PPMI), today announced the ...

At the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) in Copenhagen, Denmark, The Michael J. Fox Foundation (MJFF) was actively engaged on the ground, contributing to ...

This March, the 2026 Parkinson’s Policy Forum brought more than 300 advocates from 49 states to Washington, D.C. to deliver a unified message to Congress: people living with Parkinson’s and their ...

A new report released on March 26, 2026, by The Michael J. Fox Foundation (MJFF) shows that the annual economic impact of Parkinson’s disease and atypical parkinsonisms in the United States reached ...

For people living with Parkinson’s disease — and for the families, friends and care partners who love them — progress depends not only on scientific discovery but also the public policies that help ...